BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32965773)

  • 1. Traditional Chinese medicine may be further explored as candidate drugs for pancreatic cancer: A review.
    Gao Y; Chen S; Sun J; Su S; Yang D; Xiang L; Meng X
    Phytother Res; 2021 Feb; 35(2):603-628. PubMed ID: 32965773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current status and future prospect of pharmacotherapy for pancreatic cancer].
    Fang Y; Lai MR; Ge YQ; Zhang GJ; Cheng RB
    Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(8):1509-1516. PubMed ID: 31090312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.
    Frank TS; Sun X; Zhang Y; Yang J; Fisher WE; Gingras MC; Li M
    Cancer Lett; 2015 Jul; 363(1):1-6. PubMed ID: 25890222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-gene signaling pathways in pancreatic cancer.
    Drakaki A; Iliopoulos D
    Biomed J; 2013; 36(5):200-8. PubMed ID: 24225187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementary Chinese Herbal Medicine Therapy Improves Survival of Patients With Pancreatic Cancer in Taiwan: A Nationwide Population-Based Cohort Study.
    Kuo YT; Liao HH; Chiang JH; Wu MY; Chen BC; Chang CM; Yeh MH; Chang TT; Sun MF; Yeh CC; Yen HR
    Integr Cancer Ther; 2018 Jun; 17(2):411-422. PubMed ID: 28774207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular alterations contributing to pancreatic cancer chemoresistance.
    Rajabpour A; Rajaei F; Teimoori-Toolabi L
    Pancreatology; 2017; 17(2):310-320. PubMed ID: 28065383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of herbal medicines and natural products: an alternative approach to overcoming the apoptotic resistance of pancreatic cancer.
    Li L; Leung PS
    Int J Biochem Cell Biol; 2014 Aug; 53():224-36. PubMed ID: 24875648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor effect of the extract from qingyihuaji formula on pancreatic cancer by down-regulating Notch-4 and Jagged-1.
    Xu Y; Zhu F; Xu S; Liu L
    J Tradit Chin Med; 2015 Feb; 35(1):77-83. PubMed ID: 25842732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chinese Herbal Medicine Effectively Prolongs the Overall Survival of Pancreatic Cancer Patients: A Case Series.
    Wong W; Chen BZ; Lee AKY; Chan AHC; Wu JCY; Lin Z
    Integr Cancer Ther; 2019; 18():1534735419828836. PubMed ID: 30791742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging drugs in the treatment of pancreatic cancer.
    Mahalingam D; Kelly KR; Swords RT; Carew J; Nawrocki ST; Giles FJ
    Expert Opin Emerg Drugs; 2009 Jun; 14(2):311-28. PubMed ID: 19466902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances and developments in treatment strategies against pancreatic cancer.
    Fryer RA; Galustian C; Dalgleish AG
    Curr Clin Pharmacol; 2009 May; 4(2):102-12. PubMed ID: 19442075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Any second-line therapy for advanced pancreatic cancer? Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
    Li J; Merl MY; Saif MW
    JOP; 2010 Mar; 11(2):151-3. PubMed ID: 20208325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective induction of apoptosis: promising therapy in pancreatic cancer.
    Liu Z; Li D; Zheng X; Wang E; Wang J
    Curr Pharm Des; 2013; 19(12):2259-68. PubMed ID: 23082976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target therapies in pancreatic carcinoma.
    Silvestris N; Gnoni A; Brunetti AE; Vincenti L; Santini D; Tonini G; Merchionne F; Maiello E; Lorusso V; Nardulli P; Azzariti A; Reni M
    Curr Med Chem; 2014; 21(8):948-65. PubMed ID: 23992319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment with PPAR-γ agonists in pancreatic cancer: a glimmer of hope for cancer therapy?
    Dicitore A; Caraglia M; Colao A; Zappavigna S; Mari D; Hofland LJ; Persani L; Vitale G
    Curr Cancer Drug Targets; 2013 May; 13(4):460-71. PubMed ID: 23617255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies.
    Matsuoka T; Yashiro M
    World J Gastroenterol; 2016 Jan; 22(2):776-89. PubMed ID: 26811624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposome based delivery systems in pancreatic cancer treatment: from bench to bedside.
    Yang F; Jin C; Jiang Y; Li J; Di Y; Ni Q; Fu D
    Cancer Treat Rev; 2011 Dec; 37(8):633-42. PubMed ID: 21330062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant Chemotherapy after Surgery for Pancreatic Cancer].
    Furuse J
    Gan To Kagaku Ryoho; 2016 Feb; 43(2):160-4. PubMed ID: 27067680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin and pancreatic cancer: Current knowledge and future perspectives.
    Tamtaji OR; Mirhosseini N; Reiter RJ; Behnamfar M; Asemi Z
    J Cell Physiol; 2019 May; 234(5):5372-5378. PubMed ID: 30229898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular mechanisms of traditional Chinese medicine ZHENG syndromes on pancreatic tumor growth.
    Dai HY; Wang P; Feng LY; Liu LM; Meng ZQ; Zhu XY; Wang K; Hua YQ; Mao YX; Chen LY; Chen Z
    Integr Cancer Ther; 2010 Sep; 9(3):291-7. PubMed ID: 20702498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.